Multi-Organ Transplant Capabilities in India for International Patients 2026
When a patient's disease affects multiple organs simultaneously — kidneys and liver failing together, heart failure compounding renal disease, diabetes destroying both kidney and pancreatic function — a single-organ transplant solves only part of the problem. Multi-organ transplantation, where two organs are transplanted simultaneously from the same donor, addresses the full disease picture in one procedure. This is one of the most complex areas of transplant medicine, requiring experienced joint surgical teams, specialised ICU infrastructure, and institutional commitment that only a handful of Indian hospitals can genuinely offer.
TL;DR: Simultaneous liver-kidney transplant (SLK) costs USD 40,000–65,000 in India. Heart-kidney and pancreas-kidney combinations are also performed at top Indian centres. Multi-organ transplants require joint surgical teams and represent 60–75% cost savings versus equivalent USA programmes (Patients Beyond Borders, 2024).
Why Multi-Organ Transplantation Is Sometimes the Only Answer
The logic behind simultaneous multi-organ transplantation is clinical necessity: transplanting only one organ when two are failing leads to inferior outcomes or simply doesn't work.
Simultaneous liver-kidney (SLK): The most commonly performed multi-organ combination. Indicated when a patient has both end-stage liver disease and end-stage renal disease (or severe chronic kidney disease). Transplanting the liver alone in a patient with significant kidney disease leads to rapid post-transplant renal failure — the immunosuppressants required after liver transplant (particularly tacrolimus) are nephrotoxic, and a compromised kidney can't withstand them. SLK resolves both problems simultaneously.
Simultaneous pancreas-kidney (SPK): For Type 1 diabetics with end-stage renal disease. The kidney replaces dialysis; the pancreas restores insulin independence. SPK is the most common pancreas transplant performed globally and has excellent documented outcomes.
Heart-kidney: For patients with end-stage heart failure requiring cardiac transplant who also have significant chronic kidney disease. Performing cardiac transplant alone in a patient with eGFR under 30–40 carries very high risk of post-operative renal failure requiring dialysis — adding a kidney reduces this risk substantially.
Liver-heart: Very uncommon. Indicated in specific metabolic conditions (familial amyloid polyneuropathy, hyperoxaluria) where the liver produces a toxic protein that damages the heart, or in combined cardiac and hepatic failure.
Multivisceral (liver + intestine + pancreas ± stomach): Performed in rare cases of short bowel syndrome or specific metabolic diseases requiring intestinal replacement. Available at a very small number of Indian centres with specialised intestinal transplant experience.
Which Centres Perform Multi-Organ Transplants in India?
Multi-organ transplant is not a capability most hospitals have. The institutional requirements are demanding — two complete surgical teams available simultaneously, dedicated multi-organ transplant ICU, blood banking with specific capacity, and experienced transplant coordinators.
Centres with demonstrated active multi-organ programmes:
- Apollo Hospitals, Chennai — one of India's highest-volume combined transplant programmes, with extensive SLK and SPK experience
- Medanta The Medicity, Gurgaon — comprehensive liver, kidney, and cardiac transplant under one institutional umbrella
- Fortis Memorial Research Institute, Gurgaon — SLK and SPK programme with published outcomes
- Narayana Health, Bangalore — significant cardiac transplant volume combined with kidney programme; heart-kidney experience
- Global Hospital, Mumbai — active multi-organ programme with strong liver transplant foundation
When evaluating centres for multi-organ transplant, ask specifically: How many SLK procedures did you perform in 2024? What is your 1-year patient survival rate for SLK? Do you have dedicated multi-organ transplant ICU beds?
Costs by Procedure Combination
| Multi-Organ Combination | India (USD) | USA (USD) | Germany (EUR equiv.) |
|---|---|---|---|
| Simultaneous liver-kidney (SLK) | 40,000 – 65,000 | 250,000 – 500,000 | €150,000 – €300,000 |
| Simultaneous pancreas-kidney (SPK) | 30,000 – 45,000 | 150,000 – 300,000 | €80,000 – €150,000 |
| Heart-kidney | 55,000 – 90,000 | 300,000 – 600,000 | €200,000 – €400,000 |
| Liver-heart | 65,000 – 100,000+ | Not widely available | €250,000+ |
Sources: Patients Beyond Borders 2024; Arodya hospital quotes 2025.
Costs include the surgical procedures for both organs, dual ICU care, extended high-dependency ward stay, initial immunosuppression, and standard post-operative monitoring. The ongoing cost of immunosuppression (lifelong), additional monitoring, and any post-discharge complications are separate.
For individual organ transplant cost detail, see our guides on kidney transplant in India, liver transplant, and pancreas transplant.
The Assessment Process for Multi-Organ Transplant
Multi-organ transplant assessment is more extensive than for single-organ procedures because the surgical risk is higher and recipient selection must be more precise.
Liver-kidney assessment:
- Standard liver transplant workup (MELD score, portal hypertension assessment, hepatic arterial anatomy)
- Renal assessment (GFR measurement, renal biopsy in some cases to confirm irreversibility)
- Cardiac clearance
- HLA typing (for the kidney component)
- Assessment of the degree of renal disease — is it hepatorenal syndrome (which may resolve with liver transplant alone) or independent intrinsic renal disease?
Pancreas-kidney assessment:
- As per SPK assessment (see our pancreas transplant guide)
- Comprehensive diabetic complication assessment
- Cardiac clearance (mandatory — Type 1 diabetics with renal failure have high cardiac risk)
Heart-kidney assessment:
- Cardiac assessment: echo, cardiac catheterisation, coronary angiography
- Renal assessment: eGFR, proteinuria, renal biopsy if needed
- Panel reactive antibody (PRA) testing for both cardiac and renal crossmatch planning
What International Patients Need to Know
Multi-organ transplant cases require more lead time and preparation than single-organ transplants. The assessment process typically takes 2–4 weeks in India, surgical waiting time for a deceased donor depends on the transplant centre's donor programme, and post-operative recovery before discharge runs 4–8 weeks depending on which combination was performed.
Plan for a total India stay of 2–4 months. Family accompaniment is essential — recovery requires daily support and close monitoring. Telemedicine follow-up after return home is intensive for the first year.
For the most complex cases, Arodya sends the full case history to two or three centres simultaneously and obtains written treatment assessments including candidacy opinion, donor strategy, cost estimate, and anticipated timeline. Submit your medical records here for a coordinated multi-centre review.
